What Are the Toxicological Concerns Associated with Vinblastine?
Vinblastine, like other chemotherapeutic agents, is associated with a range of toxicological concerns. The most common adverse effects include myelosuppression, which results in decreased bone marrow activity leading to lower counts of red and white blood cells and platelets. This can increase the risk of infection, anemia, and bleeding. Gastrointestinal toxicity, including nausea, vomiting, and constipation, is also common. Neuropathy, characterized by peripheral nerve damage, can occur, leading to symptoms such as tingling and numbness in the extremities.
